INTRODUCTION AND HYPOTHESIS: Placement of a transobturator midurethral sling (MUS) is the standard surgical treatment for stress urinary incontinence.
Most recent MUS procedures have been poorly evaluated. We compared the results using a "new" device expected to reduce postoperative pain, the TVT ABBREVO® system (TVT-Abb), with those using the TVT™ obturator system (TVT-O).
METHODS: This was a retrospective study comparing the use of the TVT-Abb (in 50 patients) and the TVT-O (in 50 patients). The main outcomes were the amount of postoperative pain, the success rate (no reported urinary leakage and negative cough test) with both MUS procedures, and the prevalence of complications.
RESULTS: The mean follow-up time was 12 months. The preoperative characteristics of the two groups were comparable. There was less postoperative pain (VAS, 0 to 100) in the TVT-Abb group than in the TVT-O group (12.2 vs. 24.4, p < 0.01). However, at 6 weeks after surgery there was no significant difference between the two groups (p = 0.32). The incidence of de novo bladder outlet obstruction symptoms was similar in the TVT-Abb group and the TVT-O group (8 % vs. 12 %, p = 0.74). The prevalences of perioperative and postoperative complications (bladder/urethral injury, haemorrhage) in the two groups were equal. The success rates were similar at 12 months after surgery (88 % vs. 78 %, p = 0.29).
CONCLUSIONS: The success rates with TVT-Abb and TVT-O were equal at 12 months after surgery, but there was less immediate postoperative pain with TVT-Abb.
Written by:
Canel V, Thubert T, Wigniolle I, Fernandez H, Deffieux X. Are you the author?
Service de Gynécologie Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, APHP, Hôpitaux Universitaires Paris Sud, 157 rue de la Porte-de-Trivaux, 92140, Clamart, France.
Reference: Int Urogynecol J. 2015 May 12. Epub ahead of print.
doi: 10.1007/s00192-015-2723-8
PubMed Abstract
PMID: 25963058